{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:04:22Z","timestamp":1790899462250,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","fsigenetics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International: Genetics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.fsigen.2024.103218","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T19:47:25Z","timestamp":1735069645000},"page":"103218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Tramadol-related fatalities: Metabolic ratios & SNPs\/INDELs belonging to UGT1A8, UGT2B7, ABCC2, and SLC22A1"],"prefix":"10.1016","volume":"76","author":[{"given":"Sanaa M.","family":"Aly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"Sabaouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hennart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-michel","family":"Gaulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Allorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fsigen.2024.103218_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00414-013-0849-0","article-title":"ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram","volume":"127","author":"Karlsson","year":"2013","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.fsigen.2024.103218_bib2","article-title":"Oxycodone findings and CYP2D6 function in postmortem cases","volume":"53","author":"Jakobsson","year":"2021","journal-title":"Forensic Sci. Int.: Genet."},{"key":"10.1016\/j.fsigen.2024.103218_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.forsciint.2010.09.011","article-title":"Pharmacogenetics in medico-legal context","volume":"203","author":"Sajantila","year":"2010","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.fsigen.2024.103218_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ejps.2010.08.005","article-title":"Glucuronidation of racemic O-desmethyltramadol, the active metabolite of tramadol","volume":"41","author":"Lehtonen","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.fsigen.2024.103218_bib5","series-title":"Forensic Analysis-Scientific and Medical Techniques and Evidence under the Microscope","article-title":"Pharmacogenetics and Tramadol-Related Fatalities","author":"Aly","year":"2021"},{"key":"10.1016\/j.fsigen.2024.103218_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/clpt.2011.56","article-title":"Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol","volume":"90","author":"Tzvetkov","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.fsigen.2024.103218_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.802539","article-title":"The role of uptake and efflux transporters in the disposition of glucuronide and sulfate conjugates","volume":"12","author":"J\u00e4rvinen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fsigen.2024.103218_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.fsigen.2017.11.012","article-title":"Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype","volume":"33","author":"Wendt","year":"2018","journal-title":"Forensic Sci. Int.: Genet."},{"key":"10.1016\/j.fsigen.2024.103218_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5114\/amsik.2015.61029","article-title":"Next generation sequencing (NGS): a golden tool in forensic toolkit","volume":"65","author":"Aly","year":"2015","journal-title":"Archiwum Medycyny S\u0105dowej i Kryminologii\/Arch. Forensic Med. Criminol."},{"key":"10.1016\/j.fsigen.2024.103218_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0379-0738(03)00159-2","article-title":"Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood","volume":"135","author":"Levo","year":"2003","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.fsigen.2024.103218_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/jat\/bkab096","article-title":"Tramadol-related deaths: genetic analysis in relation to metabolic ratios","volume":"46","author":"Aly","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.fsigen.2024.103218_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.forsciint.2016.02.004","article-title":"Sequencing CYP2D6 for the detection of poor-metabolizers in post-mortem blood samples with tramadol","volume":"265","author":"Fonseca","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.fsigen.2024.103218_bib13","first-page":"94","article-title":"A genome-wide association study of tramadol metabolism from post-mortem samples","volume":"20","author":"Wendt","year":"2020","journal-title":"Pharm. J."},{"key":"10.1016\/j.fsigen.2024.103218_bib14","first-page":"1","article-title":"Metabolic ratios and SNPs implicated in tramadol-related deaths","author":"Aly","year":"2023","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.fsigen.2024.103218_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00414-018-1969-3","article-title":"Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700","volume":"133","author":"Richeval","year":"2019","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.fsigen.2024.103218_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/dta.2232","article-title":"Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs population","volume":"10","author":"Wille","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"8","key":"10.1016\/j.fsigen.2024.103218_bib17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00228-011-1080-x","article-title":"Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer","volume":"67","author":"Elkalioubie","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.fsigen.2024.103218_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000179558","article-title":"Deviations from hardy-weinberg equilibrium in parental and unaffected sibling genotype data","volume":"67","author":"Li","year":"2009","journal-title":"Hum. Hered."},{"key":"10.1016\/j.fsigen.2024.103218_bib19","first-page":"17","article-title":"Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients","volume":"3","author":"Holthe","year":"2003","journal-title":"Pharm. J."},{"key":"10.1016\/j.fsigen.2024.103218_bib20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/FPC.0b013e3283037fe4","article-title":"SNP discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene","volume":"18","author":"Innocenti","year":"2008","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.fsigen.2024.103218_bib21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pgs.12.69","article-title":"UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients","volume":"13","author":"Tian","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.fsigen.2024.103218_bib22","article-title":"Does Bonferroni correction \u201crescue\u201d the deviation from Hardy-Weinberg equilibrium?","volume":"46","author":"Ye","year":"2020","journal-title":"Forensic Sci. Int.: Genet."},{"key":"10.1016\/j.fsigen.2024.103218_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1559325817723731","article-title":"Effect of UDP-glucuronosyltransferase (UGT) 1A polymorphism (rs8330 and rs10929303) on glucuronidation status of acetaminophen","volume":"15","author":"Mehboob","year":"2017","journal-title":"Dose-Response"},{"key":"10.1016\/j.fsigen.2024.103218_bib24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/clpt.2012.96","article-title":"Pharmacogenomics knowledge for personalized medicine","volume":"92","author":"Whirl-Carrillo","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.fsigen.2024.103218_bib25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00296-016-3592-2","article-title":"Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose","volume":"37","author":"Carroll","year":"2017","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.fsigen.2024.103218_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00424-006-0109-y","article-title":"The apical conjugate efflux pump ABCC2 (MRP2)","volume":"453","author":"Nies","year":"2007","journal-title":"Pfl\u00fcgers Arch. -Eur. J. Physiol."},{"key":"10.1016\/j.fsigen.2024.103218_bib27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/humu.22041","article-title":"Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells","volume":"33","author":"Arlanov","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.fsigen.2024.103218_bib28","first-page":"279","article-title":"ABCC2 rs2273697 is associated with valproic acid concentrations in patients with epilepsy on valproic acid monotherapy","volume":"73","author":"Chen","year":"2018","journal-title":"Die Pharm. - Int. J. Pharm. Sci."},{"key":"10.1016\/j.fsigen.2024.103218_bib29","first-page":"25","article-title":"Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function","volume":"11","author":"Laechelt","year":"2011","journal-title":"Pharm. J."},{"key":"10.1016\/j.fsigen.2024.103218_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.672287","article-title":"Clinical relevance of ABCB1, ABCG2, and ABCC2 gene polymorphisms in chronic myeloid leukemia patients treated with nilotinib","volume":"11","author":"Loscocco","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.fsigen.2024.103218_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106678","article-title":"A systematic review and meta-analysis of the association of ABCC2\/ABCG2 polymorphisms with antiepileptic drug responses in epileptic patients","volume":"175","author":"Zan","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.fsigen.2024.103218_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1389200222666210114123349","article-title":"Impact of pharmacogenetic determinants of tacrolimus and mycophenolate on adverse events in renal transplant patients","volume":"22","author":"Thishya","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.fsigen.2024.103218_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2217\/pgs-2022-0171","article-title":"Gene polymorphisms affect postoperative imatinib plasma levels and edema in adults with gastrointestinal stromal tumor","volume":"24","author":"Jiang","year":"2023","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.fsigen.2024.103218_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/pgs-2017-0002","article-title":"OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children","volume":"18","author":"Balyan","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.fsigen.2024.103218_bib35","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","article-title":"Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration","volume":"86","author":"Tzvetkov","year":"2013","journal-title":"Biochem. Pharmacol."}],"container-title":["Forensic Science International: Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187249732400214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187249732400214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:43:26Z","timestamp":1740725006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187249732400214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"alternative-id":["S187249732400214X"],"URL":"https:\/\/doi.org\/10.1016\/j.fsigen.2024.103218","relation":{},"ISSN":["1872-4973"],"issn-type":[{"value":"1872-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tramadol-related fatalities: Metabolic ratios & SNPs\/INDELs belonging to UGT1A8, UGT2B7, ABCC2, and SLC22A1","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International: Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fsigen.2024.103218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103218"}}